SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cisco who wrote (1187)1/18/1998 12:24:00 AM
From: Sigmund  Read Replies (1) of 1894
 
Value of ACMI

I think that ACMI is valued in the market very differently from some of the other players in the sector such as NSIX, NPTH and CYTC.

ACMI is not a one product company
ACMI has substantial revenues.

Now you might think that these are good characteristics. But perversely these "good" characteristics have worked against the ACMI shareholder because ACMI is valued to some extent as an operating company not a development stage company.

Operating companies are valued based on earnings and cash flow not on hype.

That is why I think it very important that ACMI IR establish that the new deal makes sense structurally as if this were an operating company.

When ACMI starts reporting profits, it will be in far better shape than the other companies in the sector and the fact that it has so many irons in the fire will then be seen as a plus not the minus it is currently. Today these multiple irons are seen as a drag on the financial resources of the company causing it to sell off pieces at firesale prices. In the future multiple irons will be seen as a driver of growth.

But we have to get there first.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext